HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

 

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

 

In this episode of HOPA Now, Dr. Katie Gatwood provides an overview of the goals of and indications for hematopoietic stem cell transplantation, which is often the only curative treatment option for several malignant and non-malignant diseases. She covers the goals and considerations of hematopoietic stem cell transplantation, common indications for allogeneic transplants, the three conditioning chemotherapy regimens that are administered prior to stem cell infusion, and key supportive considerations for hematopoietic stem cell transplant recipients.

 

In this episode you will learn:

 

Hematopoietic stem cell transplantation and opportunistic infections

• The goals of hematopoietic stem cell transplantation include eradicating disease, restoring normal hematopoiesis, and to induce immunologic activity to prevent disease relapse.
• Stem cell transplantation considerations and donor options for transplants
• Common indications for allogeneic transplants and sources of hematopoietic stem cells
• Three conditioning chemotherapy regimens that are administered prior to stem cell infusion
• Leading causes of transplant-related morbidity and mortality
• Understanding infection as one of the leading causes of transplant-related mortality
• Key supportive considerations for hematopoietic stem cell transplant recipients

 

Mentioned in This Episode:

HOPA

 

Tweetables:

“Stem cell transplantation is used only to administer high dose chemotherapy.” — Dr. Katie Gatwood

 

“Peripheral blood is most commonly utilized due to ease of collection and low graft failure rate and faster engraftment time.” — Dr. Katie Gatwood

 

“Stem cell transplant infection is one of the leading causes of transplant-related mortality.” — Dr. Katie Gatwood